A recent study on PGR variants in metastatic ER(+) BC demonstrated that 3 out of 4 samples of functionally deleterious Y890C variant were PgR(−) by IHC, so this specific variant may contribute to PgR loss by clonal selection [35]. Here, ESR1 is linked to breast cancer.